A novel TARDBP mutation in an Australian amyotrophic lateral sclerosis kindred

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder that causes loss of motor neurons. A pathological hallmark of ALS is the presence of ubiquitinated TAR DNA binding protein (TDP-43) inclusions in the cytoplasm of affected cells. Rare pathogenic mutations within the gene TARDBP that encode TDP-43 were recently reported in ALS but their functional consequences are unknown. To further investigate the pathogenic role of TDP-43 in ALS, a mutation analysis of TARDBP was performed in an Australian cohort of 74 sporadic and 30 familial ALS cases. A novel familial ALS mutation in TDP-43 was identified that substitutes a highly conserved residue (G294V) and is predicted to disrupt the glycine rich domain in the C terminus, a region that plays a role in RNA binding and is required for the exon skipping activity of TDP-43.

[1]  P. Deyn,et al.  Neuronal inclusion protein TDP-43 has no primary genetic role in FTD and ALS , 2009, Neurobiology of Aging.

[2]  N. Cairns,et al.  ALS and FTLD: two faces of TDP‐43 proteinopathy , 2008, European journal of neurology.

[3]  A. Singleton,et al.  TDP-43 Is Not a Common Cause of Sporadic Amyotrophic Lateral Sclerosis , 2008, PloS one.

[4]  I-Fan Wang,et al.  TDP‐43, the signature protein of FTLD‐U, is a neuronal activity‐responsive factor , 2008, Journal of neurochemistry.

[5]  Xun Hu,et al.  TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis , 2008, Science.

[6]  G. Rouleau,et al.  Genetics of familial amyotrophic lateral sclerosis , 2008, Neurology.

[7]  E. Buratti,et al.  Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease. , 2008, Frontiers in bioscience : a journal and virtual library.

[8]  R. Henry,et al.  Establishing subtypes of the continuum of frontal lobe impairment in amyotrophic lateral sclerosis. , 2007, Archives of neurology.

[9]  H. Akiyama,et al.  TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. , 2006, Biochemical and biophysical research communications.

[10]  C. Shaw,et al.  Amyotrophic Lateral Sclerosis/Motor Neuron Disease , 2006 .

[11]  K. Talbot,et al.  Recent advances in the genetics of amyotrophic lateral sclerosis and frontotemporal dementia: common pathways in neurodegenerative disease. , 2006, Human molecular genetics.

[12]  Bruce L. Miller,et al.  Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.

[13]  K. Morrison,et al.  Amyotrophic lateral sclerosis (motor neuron disease): proposed mechanisms and pathways to treatment , 2006, Expert Reviews in Molecular Medicine.

[14]  R. Weksberg,et al.  A method for accurate detection of genomic microdeletions using real-time quantitative PCR , 2005, BMC Genomics.

[15]  Hurng‐Yi Wang,et al.  Structural diversity and functional implications of the eukaryotic TDP gene family. , 2004, Genomics.

[16]  A Hofman,et al.  Genetic epidemiology of amyotrophic lateral sclerosis , 2003, Clinical genetics.

[17]  M. Swash,et al.  El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.